These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8914464)

  • 1. [Activated protein C resistance in the Japanese].
    Ozawa T
    Rinsho Ketsueki; 1996 Sep; 37(9):790-3. PubMed ID: 8914464
    [No Abstract]   [Full Text] [Related]  

  • 2. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Japanese patients with various forms of thrombosis, and normal individuals.
    Zama T; Murata M; Ono F; Watanabe K; Watanabe R; Moriki T; Yokoyama K; Tokuhira M; Ikeda Y
    Int J Hematol; 1996 Dec; 65(1):71-8. PubMed ID: 8990627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C resistance and inherited thrombosis.
    Rodgers GM
    Am J Clin Pathol; 1995 Mar; 103(3):261-2. PubMed ID: 7872247
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitivity and specificity of the APC resistance assay in detection of individuals with factor V Leiden.
    Zehnder JL; Benson RC
    Am J Clin Pathol; 1996 Jul; 106(1):107-11. PubMed ID: 8701918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation factor V Leiden mutation may have a racial background.
    Fujimura H; Kambayash J; Monden M; Kato H; Miyata T
    Thromb Haemost; 1995 Nov; 74(5):1381-2. PubMed ID: 8607128
    [No Abstract]   [Full Text] [Related]  

  • 6. [Resistance to activated protein C--a novel cause of thrombophilia].
    Cycowitz Z; Seligsohn U; Zivelin A; Eldor A
    Harefuah; 1995 Jul; 129(1-2):1-5, 80. PubMed ID: 7557699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype.
    Okada H; Toyoda Y; Takagi A; Saito H; Kojima T; Yamazaki T
    Int J Hematol; 2010 Apr; 91(3):549-50. PubMed ID: 20300981
    [No Abstract]   [Full Text] [Related]  

  • 8. Activated protein C resistance and the factor V Leiden mutation in children with thrombosis.
    Sifontes MT; Nuss R; Hunger SP; Waters J; Jacobson LJ; Manco-Johnson M
    Am J Hematol; 1998 Jan; 57(1):29-32. PubMed ID: 9423813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predisposition to thrombosis by a factor V mutation causing hereditary resistance to activated protein C.
    Press RD; Goodnight SH
    West J Med; 1995 May; 162(5):450-2. PubMed ID: 7785262
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombosis in otherwise well children with the factor V Leiden mutation.
    Sifontes MT; Nuss R; Jacobson LJ; Griffin JH; Manco-Johnson MJ
    J Pediatr; 1996 Mar; 128(3):324-8. PubMed ID: 8774498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis.
    Dahlbäck B
    Rev Invest Clin; 1997 May; 49 Suppl 1():3-5. PubMed ID: 9291738
    [No Abstract]   [Full Text] [Related]  

  • 12. High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis.
    Beauchamp NJ; Daly ME; Hampton KK; Cooper PC; Preston FE; Peake IR
    Br J Haematol; 1994 Sep; 88(1):219-22. PubMed ID: 7803250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factor V Leiden and activated protein C resistance].
    Cauchie P; Hilbert P
    Rev Med Brux; 1997 Jun; 18(3):97-102. PubMed ID: 9273603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited thrombotic disorders: an update.
    Florell SR; Rodgers GM
    Am J Hematol; 1997 Jan; 54(1):53-60. PubMed ID: 8980261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [APC resistance and blood coagulation factor V mutation in Finnish thrombotic patients].
    Hakala L; Vahtera E; Krusius T; Rasi V
    Duodecim; 1995; 111(22):2143-51. PubMed ID: 9841174
    [No Abstract]   [Full Text] [Related]  

  • 16. Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy.
    Hallak M; Senderowicz J; Cassel A; Shapira C; Aghai E; Auslender R; Abramovici H
    Am J Obstet Gynecol; 1997 Apr; 176(4):889-93. PubMed ID: 9125617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the ProC Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation.
    Quincampoix JC; Legarff M; Rittling C; Andiva S; Toulon P
    Blood Coagul Fibrinolysis; 2001 Oct; 12(7):569-76. PubMed ID: 11685046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombophilia: the new factor is old factor V.
    Tuddenham EG
    Lancet; 1994 Jun; 343(8912):1515-6. PubMed ID: 7911865
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular genetics of thrombophilia: factor V gene mutation causing resistance to activated protein C as a basis of the hypercoagulable state.
    Dahlbäck B
    J Lab Clin Med; 1995 May; 125(5):566-71. PubMed ID: 7738422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.